(Q45200184)

10 December 2017

title

Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women (English)

1 reference

10 December 2017

1 reference

1 reference

1 reference

2

1 reference

10 December 2017

4

1 reference

10 December 2017

5

1 reference

European Collaborative Study

10 December 2017

series ordinal

1

object named as

European Collaborative Study

1 reference

10 December 2017

Mario Cortina-Borja

3

1 reference

10 December 2017

language of work or name

English

0 references

publication date

2 May 2007

1 reference

Clinical Infectious Diseases

10 December 2017

published in

1 reference

10 December 2017

volume

44

1 reference

10 December 2017

issue

12

1 reference

10 December 2017

page(s)

1647-1656

1 reference

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

10 December 2017

cites work

1 reference

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy

21 January 2018

1 reference

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

21 January 2018

1 reference

Tutorial in biostatistics methods for interval-censored data

21 January 2018

1 reference

Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.

21 January 2018

1 reference

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

21 January 2018

1 reference

Pharmacokinetics of antiretrovirals in pregnant women

21 January 2018

1 reference

Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women

21 January 2018

1 reference

Nelfinavir plasma concentrations are low during pregnancy

21 January 2018

1 reference

The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum.

21 January 2018

1 reference

A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission

21 January 2018

1 reference

Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana

21 January 2018

1 reference

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy

21 January 2018

1 reference

HIV-1 subtypes: epidemiology and significance for HIV management

21 January 2018

1 reference

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study

21 January 2018

1 reference

The influence of pregnancy on human immunodeficiency virus type 1 infection: antepartum and postpartum changes in human immunodeficiency virus type 1 viral load

21 January 2018

1 reference

Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups

21 January 2018

1 reference

Comparative pharmacogenomics of antiretroviral and cytotoxic treatments.

21 January 2018

1 reference

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

21 January 2018

1 reference

Reduced lopinavir exposure during pregnancy

21 January 2018

1 reference

The Impact of Race/Ethnicity on Mother-to-Child HIV Transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/518284

1 reference

10 December 2017

1 reference